The global fibrin sealants market size is anticipated to reach USD 1,156.6 million by 2026, displaying a CAGR of 6.6% during the forecast period. Rising prevalence of cardiovascular diseases (CVDs) worldwide is likely to play a vital role in driving the growth of this market in the coming years. According to estimates released by the World Health Organization (WHO), CVDs have become the number one cause of death globally, responsible for the death of over 17 million people around the world. These diseases are causing high mortality even in developed countries. For instance, the American College of Cardiology states that CVDs killed close to 840,768 Americans in 2016. CVDs are chronic in nature and eventually require invasive surgeries. Fibrin sealants are critical components in surgeries, especially those of the heart, as they are the most effective and efficient tissue adhesives available in the market. Thus, as the incidence of heart surgeries rises, the demand for fibrin glues will grow, as per the fibrin sealants market analysis.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/fibrin-sealants-market-100316
Prominent Players Profiled in the Fibrin Sealants Market Report:
- Vivostat A/S
- Johnson & Johnson Services, Inc.
- CSL Limited
- Takeda Pharmaceutical Company Limited
The new Fortune Business Insights™ report, titled “Fibrin Sealants Market Size, Share & Industry Analysis, By Type (Liquid, and Patches) By Application (Orthopedic Surgery, Cardiovascular surgery, General Surgery, Transplant Surgery, and Others) By End User (Hospitals, Specialty Clinics, and Others) and Regional Forecast, 2019-2026”, states that the value of the market stood at USD 701.4 million in 2018. The report further shares the following information:
- Comprehensive analysis of the upcoming trends and prospects in the market;
- 360-degree evaluation of the factors driving and restraining market growth;
- Detailed research into the regional and competitive landscape influencing the market; and
- Careful study of the market segments.
For more information in the analysis of this report, visit:
Growing Usage of Hemostats in Operative Procedures to Feed Market Growth
One of the top fibrin sealants market trends is the high demand and utilization of hemostats for surgeries. Hemostats, or clamps, are devices used in surgical procedures to control bleeding. They are widely employed in complex procedures, such as during cardiac surgeries, where utmost care needs to be taken. The demand for these devices is further bolstered by the fact that the number of heart surgeries in the world is escalating. A survey conducted by the American Hospital Association found that in 2014 approximately 17.2 million patients had to undergo invasive cardiac surgery in the US. Furthermore, increasing demand for these materials has prompted market players to innovate and launch new products. For example, Baxter unveiled its new Tisseel Prima Syringe, an ergonomic device that is fully assembled and much more convenient to use than its older variant, in November 2018.
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Market Drivers
- Market Restraints
- Market Opportunities
- Technological Advancements in Fibrin Sealants Market
- New Product Launches by Key Players
- Key Industry Developments: Mergers, Acquisitions & Partnerships
- Overview of Regulatory Scenario - Key Countries
- Prevalence of Major Surgical Procedures for Key Countries
- Trends of Usage of Fibrin Sealants
More Trending Topics from Fortune Business Insights:
Cosmetic Surgery Market Global Industry Size, Segments, Share and Growth Factor Analysis Research Report 2026
Wound Closure Market 2020 Global Industry Growth, Size, Demand, Trends, Insights, Regional Overview and Forecast 2026
Albumin Market 2020 Global Growth, Size, Demand, Trends, Industry Insights, Analysis and Forecast 2026
Contract Manufacturing Organization (CMO) Market Developments, Segmentation, Global Opportunities, Trends, Analysis and Share by Forecast to 2026